The following is my one post at the other board in

The following is my one post at the other board in response to the worm that glows in the dark. When Dr. Hirsch first came on board I was immediately impressed with his vast knowledge of the biotech industry. I put together in chronological order his credentials. Come on let's be honest...could there be a better fit for OWCP? This dude is the real deal and I now, yes now, have full confidence in the leadership of this company and its prospects for the future. And the fact that he speaks perfect English that we can all understand, as trivial as it may seem, is a real bonus.... remember Ziv?

Quote:

---

I find it quite insulting that you would refer to an outstanding individual as an "ass" and "clown". The following is part of Dr. Hirsch's extensive resume. By all means share with us your own resume and then we can all judge who is the ass here.

BUSINESS & EDUCATION EXPERIENCE
• Dr. Stanley Hirsch is 59 years old.
• He obtained his Doctorate in Cell Biology and Immunology from Oxford University, UK in 1982. Having previously earned a B.Sc. degree with honors in Medical Biochemistry from the University of Capetown, South Africa in 1979, among other academic honors and awards from both Oxford University and the University of Capetown.
• After graduating, Dr. Hirsch served as General Manager of two diagnostics development companies, including Portman Pharmaceutical Industries.
• Dr. Stanley Hirsch joined CBD Technologies in March 1995 and served as its Chief Executive Officer from 1998. He also served as President of CBD Technologies, Ltd., and during that time served as an Executive Director of Foamix Pharmaceuticals Ltd.
• Prior to CBD, he was responsible for business development for a privately held group of healthcare companies, where he was responsible for structuring and managing joint ventures, startup companies, technology licensing and new product acquisitions.
• Since August 17, 2007, Dr. Hirsch, has been the Group Chief Executive Officer and Executive Director at FuturaGene plc, and also serves as its President. During this time he has also been Chief Executive Officer of FuturaGene Limited and served as Chairman of its Board of Directors.
• Dr. Hirsch has had extensive executive and board level experience for more than the past 25 years in private and publicly listed companies in biopharmaceutical and agricultural biotech industries, among others, including direct experience in raising capital and leading M&A activity together with multi-cultural management skills, having managed companies in Israel, Brazil, UK, China and the United States.
• He has been involved in the development of automated systems for plant tissue culture and is a Co-Inventor of patents in Plant Biotechnology and Micro Propagation Systems.
• Dr. Hirsch has served as an Advisor to Venture Capital Funds and as a strategy and business development Advisor to various companies in the field of drug development, tissue regeneration and diagnostics.
• He has filled various board of director, general management and business development positions in the pharmaceutical and genetic diagnostics fields.
• Since May 16, 2016, Dr. Hirsch has been the Chairman of Foamix Pharmaceuticals Ltd., and a Director since February 2005.
• Since July 24, 2017, Dr, Hirsch has been Chairman and Director of OWC Pharmaceutical Research Corp.

Perhaps you might want to watch and listen to the following GapSummit 2016 interview with Dr. Hirsch to determine whether or not he comes across as an ass.

https://www.youtube.com/watch?v=JO4I935ByKs

---